PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11714877-8	2001	CYP2C6 mRNA levels were 4 times higher in midazolam-treated animals.	Midazolam	42-51	cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1	Rattus norvegicus	0-6	
29979512-2	2017	Tolbutamide, chlorzoxazone, theophylline, midazolam, omeprazole and dextromethorphanwere used as substrates of CYP2C6, CYP2E1, CYP1A2, CYP3A2, CYP2D1, and CYP2D2 to test the depressionimpact on drug metabolism.	Midazolam	42-51	cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1	Rattus norvegicus	111-117	
11911841-2	2002	Among the metabolic reactions studied, diclofenac 4-hydroxylation (DFH), dextromethorphan O-demethylation (DMOD) and midazolam 4-hydroxylation were specifically catalyzed by CYP2C6, CYP2D2 and CYP3A1/3A2, respectively.	Midazolam	117-126	cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1	Rattus norvegicus	174-180	
11911841-3	2002	These results suggest that diclofenac 4-hydroxylation, dextromethorphan O-demethylation and midazolam 4-hydroxylation are useful as catalytic markers of CYP2C6, CYP2D2 and CYP3A1/3A2, respectively.	Midazolam	92-101	cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1	Rattus norvegicus	153-159	
19219745-4	2009	Testosterone, propranolol, diclofenac, and midazolam were determined as specific substrates of rat CYP2C11, CYP2D2, CYP2C6, and CYP3A, respectively.	Midazolam	43-52	cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1	Rattus norvegicus	116-122